TaiMed Biologics Inc. (TPEX:4147)

TaiMed Biologics Statistics

Total Valuation

TPEX:4147 has a market cap or net worth of TWD 13.46 billion. The enterprise value is 12.28 billion.

Market Cap	13.46B
Enterprise Value	12.28B

Important Dates

The next estimated earnings date is Monday, August 10, 2026.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4147 has 273.20 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	273.20M
Shares Outstanding	273.20M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	1.55%
Owned by Institutions (%)	7.11%
Float	182.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.38
PB Ratio	3.54
P/TBV Ratio	3.98
P/FCF Ratio	173.23
P/OCF Ratio	134.05
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-97.72
EV / Sales	20.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	158.04

Financial Position

The company has a current ratio of 16.83, with a Debt / Equity ratio of 0.12.

Current Ratio	16.83
Quick Ratio	9.23
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	5.89
Interest Coverage	-15.07

Financial Efficiency

Return on equity (ROE) is -3.22% and return on invested capital (ROIC) is -2.27%.

Return on Equity (ROE)	-3.22%
Return on Assets (ROA)	-2.08%
Return on Invested Capital (ROIC)	-2.27%
Return on Capital Employed (ROCE)	-3.58%
Weighted Average Cost of Capital (WACC)	3.51%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.13
Inventory Turnover	0.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.45% in the last 52 weeks. The beta is -0.12, so TPEX:4147's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	-35.45%
50-Day Moving Average	51.20
200-Day Moving Average	63.54
Relative Strength Index (RSI)	48.03
Average Volume (20 Days)	1,414,326

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4147 had revenue of TWD 601.19 million and -125.62 million in losses. Loss per share was -0.46.

Revenue	601.19M
Gross Profit	253.38M
Operating Income	-159.05M
Pretax Income	-125.62M
Net Income	-125.62M
EBITDA	-10.78M
EBIT	-159.05M
Loss Per Share	-0.46

Balance Sheet

The company has 1.64 billion in cash and 457.66 million in debt, with a net cash position of 1.18 billion or 4.32 per share.

Cash & Cash Equivalents	1.64B
Total Debt	457.66M
Net Cash	1.18B
Net Cash Per Share	4.32
Equity (Book Value)	3.80B
Book Value Per Share	13.90
Working Capital	2.99B

Cash Flow

In the last 12 months, operating cash flow was 100.37 million and capital expenditures -22.70 million, giving a free cash flow of 77.67 million.

Operating Cash Flow	100.37M
Capital Expenditures	-22.70M
Depreciation & Amortization	148.27M
Net Borrowing	-29.66M
Free Cash Flow	77.67M
FCF Per Share	0.28

Margins

Gross margin is 42.15%, with operating and profit margins of -26.46% and -20.90%.

Gross Margin	42.15%
Operating Margin	-26.46%
Pretax Margin	-20.90%
Profit Margin	-20.90%
EBITDA Margin	-1.79%
EBIT Margin	-26.46%
FCF Margin	12.92%

Dividends & Yields

TPEX:4147 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	-0.93%
FCF Yield	0.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5